These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 20638374)

  • 1. Making sense of epidemiological studies of young children exposed to thimerosal in vaccines.
    Dórea JG
    Clin Chim Acta; 2010 Nov; 411(21-22):1580-6. PubMed ID: 20638374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling neurodevelopment outcomes and ethylmercury exposure from thimerosal-containing vaccines.
    Dórea JG; Marques RC
    Toxicol Sci; 2008 Jun; 103(2):414-5; author reply 416. PubMed ID: 18364366
    [No Abstract]   [Full Text] [Related]  

  • 3. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.
    Thompson WW; Price C; Goodson B; Shay DK; Benson P; Hinrichsen VL; Lewis E; Eriksen E; Ray P; Marcy SM; Dunn J; Jackson LA; Lieu TA; Black S; Stewart G; Weintraub ES; Davis RL; DeStefano F;
    N Engl J Med; 2007 Sep; 357(13):1281-92. PubMed ID: 17898097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mercury in vaccines].
    Hessel L
    Bull Acad Natl Med; 2003; 187(8):1501-10. PubMed ID: 15146581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink.
    Young HA; Geier DA; Geier MR
    J Neurol Sci; 2008 Aug; 271(1-2):110-8. PubMed ID: 18482737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thimerosal exposure (from tetanus-diphtheria vaccine) during pregnancy and neurodevelopment of breastfed infants at 6 months.
    Marques RC; Dórea JG; Bernardi JV
    Acta Paediatr; 2010 Jun; 99(6):934-9. PubMed ID: 20003103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.
    Rooney JP
    Pediatrics; 2008 Oct; 122(4):902; author reply 902-3. PubMed ID: 18829819
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis.
    Geier D; Geier MR
    Int J Toxicol; 2004; 23(6):369-76. PubMed ID: 15764492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases.
    Verstraeten T; Davis RL; DeStefano F; Lieu TA; Rhodes PH; Black SB; Shinefield H; Chen RT;
    Pediatrics; 2003 Nov; 112(5):1039-48. PubMed ID: 14595043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism.
    Price CS; Thompson WW; Goodson B; Weintraub ES; Croen LA; Hinrichsen VL; Marcy M; Robertson A; Eriksen E; Lewis E; Bernal P; Shay D; Davis RL; DeStefano F
    Pediatrics; 2010 Oct; 126(4):656-64. PubMed ID: 20837594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evidence for the safety of thiomersal in newborn and infant vaccines.
    Clements CJ
    Vaccine; 2004 May; 22(15-16):1854-61. PubMed ID: 15121295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mercury in vaccines and developmental problems: the latest research.
    Child Health Alert; 2007 Oct; 25():3. PubMed ID: 18273929
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines.
    Tozzi AE; Bisiacchi P; Tarantino V; De Mei B; D'Elia L; Chiarotti F; Salmaso S
    Pediatrics; 2009 Feb; 123(2):475-82. PubMed ID: 19171612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.
    Andrews N; Miller E; Grant A; Stowe J; Osborne V; Taylor B
    Pediatrics; 2004 Sep; 114(3):584-91. PubMed ID: 15342825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service.
    Neonatal Netw; 1999 Sep; 18(6):65, 72. PubMed ID: 10690100
    [No Abstract]   [Full Text] [Related]  

  • 16. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.
    Heron J; Golding J;
    Pediatrics; 2004 Sep; 114(3):577-83. PubMed ID: 15342824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time of perinatal immunization, thimerosal exposure and neurodevelopment at 6 months in breastfed infants.
    Marques RC; Dórea JG; Manzatto AG; Bastos WR; Bernardi JV; Malm O
    Acta Paediatr; 2007 Jun; 96(6):864-8. PubMed ID: 17465985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter to the editor. The safety of thimerosal in newborn and infant vaccines.
    Thompson WW; DeStefano F; Chen R
    Vaccine; 2004 Dec; 23(3):281-2. PubMed ID: 15530668
    [No Abstract]   [Full Text] [Related]  

  • 19. When science is not enough - a risk/benefit profile of thiomersal-containing vaccines.
    Clements CJ; McIntyre PB
    Expert Opin Drug Saf; 2006 Jan; 5(1):17-29. PubMed ID: 16370953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast-feeding does a lot more than reduce pain in vaccinated neonates and infants.
    Dórea JG
    J Pediatr; 2009 Jun; 154(6):935-6; author reply 936. PubMed ID: 19446104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.